Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.11
-0.04 (-0.65%)
Mar 20, 2026, 10:07 AM EDT - Market open

Puma Biotechnology Revenue

In the year 2025, Puma Biotechnology had annual revenue of $228.37M, down -0.91%. Puma Biotechnology had revenue of $75.45M in the quarter ending December 31, 2025, with 27.72% growth.

Revenue (ttm)
$228.37M
Revenue Growth
-0.91%
P/S Ratio
1.37
Revenue / Employee
$1,275,816
Employees
179
Market Cap
310.86M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025228.37M-2.10M-0.91%
Dec 31, 2024230.47M-5.17M-2.19%
Dec 31, 2023235.64M7.61M3.34%
Dec 31, 2022228.03M-25.12M-9.92%
Dec 31, 2021253.16M28.05M12.46%
Dec 31, 2020225.11M-47.15M-17.32%
Dec 31, 2019272.26M21.27M8.47%
Dec 31, 2018250.99M223.31M806.60%
Dec 31, 201727.69M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition